Pharmaceuticals: Major · attribution context sourced from stored price moves, stored event labels, and peer-relative residuals inside the XLV constituent company universe.
Review priority 100 · Source rank 0 · Volume 12.9x
Source gap missing_direct_company_catalyst · Next action research_company_specific_news
Decomposition: Macro +2.05% · Sector +1.36% · Industry +1.20% · Peer Specific +0.00% · Company Catalyst +0.00% · Unexplained Residual +39.36%Review priority 100 · Source rank 0 · Volume 16.7x
Source gap missing_direct_company_catalyst · Next action research_company_specific_news
Decomposition: Macro +2.68% · Sector -1.31% · Industry +0.19% · Peer Specific +0.00% · Company Catalyst +0.00% · Unexplained Residual +38.30%Review priority 100 · Source rank 0 · Volume 15.4x
Source gap missing_direct_company_catalyst · Next action research_company_specific_news
Decomposition: Macro +0.18% · Sector +0.49% · Industry +0.50% · Peer Specific +0.00% · Company Catalyst +0.00% · Unexplained Residual +37.16%Review priority 100 · Source rank 0 · Volume 19.1x
Source gap missing_direct_company_catalyst · Next action research_company_specific_news
Decomposition: Macro +1.39% · Sector -1.55% · Industry -0.91% · Peer Specific +0.00% · Company Catalyst +0.00% · Unexplained Residual -28.17%Review priority 100 · Source rank 0 · Volume 11.9x
Source gap missing_direct_company_catalyst · Next action research_company_specific_news
Decomposition: Macro -0.42% · Sector +0.64% · Industry +1.10% · Peer Specific +0.00% · Company Catalyst +0.00% · Unexplained Residual +24.79%Review priority 95 · Source rank 0 · Volume 6.5x
Source gap missing_direct_company_catalyst · Next action research_company_specific_news
Decomposition: Macro +1.04% · Sector -0.10% · Industry +0.62% · Peer Specific +0.00% · Company Catalyst +0.00% · Unexplained Residual +15.95%Review priority 82 · Source rank 0 · Volume 4.3x
Source gap missing_direct_company_catalyst · Next action research_company_specific_news
Decomposition: Macro +0.20% · Sector -0.09% · Industry +0.04% · Peer Specific +0.00% · Company Catalyst +0.00% · Unexplained Residual +9.94%Review priority 80 · Source rank 0 · Volume 5.0x
Source gap missing_direct_company_catalyst · Next action research_company_specific_news
Decomposition: Macro +0.25% · Sector -0.04% · Industry -0.01% · Peer Specific +0.00% · Company Catalyst +0.00% · Unexplained Residual +9.26%| Date | Label | Move | Residual after context | Scope | Confidence |
|---|---|---|---|---|---|
| Mar 13, 2020 | Broad market moved +8.09% with this stock | +13.51% | +12.00% | Macro | 58% |
| Oct 1, 2025 | Closest peers moved +3.80% with this stock | +10.09% | +6.29% | Peer | 58% |
| Mar 17, 2020 | Broad market moved +5.76% with this stock | +8.38% | +4.88% | Macro | 58% |
| Nov 9, 2020 | Barron's Picks And Pans: Apollo Global, Biogen, Biden Picks And More - Benzinga | -28.17% | +0.16% | Direct | 65% |
| Mar 12, 2020 | Broad market moved -9.19% with this stock | -8.62% | -2.65% | Macro | 58% |
| Feb 6, 2026 | Biogen Inc. 10-K: 10-K | +8.53% | +0.66% | Direct | 90% |
| Feb 6, 2026 | Biogen Inc. 8-K: 8-K | +8.53% | +0.66% | Direct | 74% |
| Feb 6, 2026 | NASDAQ:BIIB 8-K current report items 2.02,9.01 | +8.53% | +0.66% | Direct | 94% |